Analysis of the Effect of IL-1β on Blood—Brain Barrier Permeability in M6 Glioma Mouse Model Using Intravital Microscopy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the effect of IL-1β on the permeability of brain capillaries in healthy mice. Intravital microscopy demonstrated that parenteral administration of IL-1β was followed by an increase in vascular permeability ensuring passage of free Alexa488 fluorescent label through the capillary walls, but not sufficient for penetration of liposomes. In addition, experiments on mice with intracranial M6 glioma showed penetration of liposomes through the walls of tumor capillaries after parenteral administration of IL-1β in a concentration of 2 μg/ml. Thus, the use of proinflammatory cytokine IL-1β in the therapy of brain tumors can significantly increase the therapeutic efficacy of drug delivery systems, in particular, for drugs poorly crossing the blood—brain barrier.

About the authors

P. A. Melnikov

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: marat.valikhov@gmail.com
Russian Federation, Moscow

M. P. Valikhov

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Author for correspondence.
Email: marat.valikhov@gmail.com
Russian Federation, Moscow

I. I. Kuznetsov

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: marat.valikhov@gmail.com
Russian Federation, Moscow

N. F. Grinenko

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: marat.valikhov@gmail.com
Russian Federation, Moscow

K. K. Sukhinich

N. K. Koltsov Institute of Developmental Biology

Email: marat.valikhov@gmail.com
Russian Federation, Moscow

A. S. Simbirtsev

State Research Institute of Highly Pure Biopreparations

Email: marat.valikhov@gmail.com
Russian Federation, St. Petersburg

Z. I. Kekelidze

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: marat.valikhov@gmail.com
Russian Federation, Moscow

V. P. Chekhonin

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation

Email: marat.valikhov@gmail.com
Russian Federation, Moscow


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies